N4 Pharma (LON:N4P) Trading 42.9% Higher – Still a Buy?

N4 Pharma Plc (LON:N4PGet Free Report) shares rose 42.9% during mid-day trading on Wednesday . The company traded as high as GBX 0.75 ($0.01) and last traded at GBX 0.75 ($0.01). Approximately 5,898,019 shares changed hands during trading, an increase of 288% from the average daily volume of 1,520,097 shares. The stock had previously closed at GBX 0.53 ($0.01).

N4 Pharma Trading Up 24.8 %

The company has a debt-to-equity ratio of 1.62, a quick ratio of 7.28 and a current ratio of 22.73. The stock has a fifty day moving average of GBX 0.62 and a 200-day moving average of GBX 0.57. The company has a market cap of £2.59 million, a PE ratio of -55.00 and a beta of -0.37.

N4 Pharma Company Profile

(Get Free Report)

N4 Pharma is a specialist pharmaceutical company developing novel delivery systems for oncology, gene therapy and vaccines It has a unique silica nanoparticle delivery system called Nuvec® and another unique peptide.lipid system called Liptide® which it operates through its subsidiary Nanogenics Ltd

N4 Pharma’s business model is to partner with companies developing novel antigens in these fields to use Nuvec® as the delivery vehicle for these antigens.

Further Reading

Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.